CymaBay Therapeutics Inc. ROE 2013-2023 | CBAY

Current and historical return on equity (ROE) values for CymaBay Therapeutics Inc. (CBAY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2023-12-31 $-0.11B $0.29B -51.08%
2023-09-30 $-0.09B $0.33B -63.41%
2023-06-30 $-0.08B $0.11B -106.49%
2023-03-31 $-0.11B $0.10B -153.19%
2022-12-31 $-0.11B $0.04B -150.18%
2022-09-30 $-0.11B $0.06B -112.04%
2022-06-30 $-0.11B $0.08B -102.69%
2022-03-31 $-0.10B $0.11B -93.09%
2021-12-31 $-0.09B $0.13B -80.00%
2021-09-30 $-0.08B $0.09B -68.82%
2021-06-30 $-0.07B $0.11B -50.84%
2021-03-31 $-0.06B $0.13B -37.71%
2020-12-31 $-0.05B $0.14B -31.83%
2020-09-30 $-0.06B $0.16B -37.43%
2020-06-30 $-0.08B $0.17B -42.70%
2020-03-31 $-0.09B $0.18B -45.43%
2019-12-31 $-0.10B $0.19B -45.69%
2019-09-30 $-0.09B $0.21B -41.96%
2019-06-30 $-0.09B $0.24B -39.91%
2019-03-31 $-0.08B $0.26B -38.77%
2018-12-31 $-0.07B $0.17B -37.97%
2018-09-30 $-0.06B $0.19B -34.50%
2018-06-30 $-0.05B $0.20B -32.93%
2018-03-31 $-0.04B $0.21B -40.41%
2017-12-31 $-0.03B $0.09B -59.02%
2017-09-30 $-0.03B $0.09B -113.73%
2017-06-30 $-0.03B $0.00B -432.00%
2017-03-31 $-0.03B $0.01B -263.16%
2016-12-31 $-0.03B $0.00B -211.76%
2016-09-30 $-0.03B $0.01B -138.67%
2016-06-30 $-0.03B $0.02B -106.12%
2016-03-31 $-0.02B $0.02B -79.21%
2015-12-31 $-0.02B $0.03B -61.86%
2015-09-30 $-0.02B $0.03B -106.02%
2015-06-30 $-0.02B $0.02B -115.79%
2015-03-31 $-0.02B $0.02B -145.45%
2014-12-31 $-0.03B $0.01B -216.95%
2014-09-30 $0.19B $0.03B 1206.25%
2014-06-30 $0.24B $0.01B 1668.97%
2014-03-31 $0.24B $0.01B 1920.00%
2013-12-31 $0.24B $0.02B 2502.56%
2013-09-30 $0.03B $0.02B 560.00%